rawfin.tv
Cardiff Oncology Reports Q3 Loss, Misses EPS Estimates
EarningsstocksAI Generated

Cardiff Oncology Reports Q3 Loss, Misses EPS Estimates

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Cardiff Oncology (CRDF) reported a quarterly loss of $0.14 per share, falling short of analyst expectations by $0.02. The company's earnings results indicate a miss on profitability targets for the period.

CRDFEarnings MissBiotechnologyFinancial Results

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks